PEAR Therapeutics Archives -

The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is

Digital therapeutics: a new frontier of medicine

https://pharmaphorum.com/digital/digital-therapeutics-a-new-frontier-of-medicine/

Digital health firm Pear goes public, raising $175 million

Phil Taylor digital, digital health, financing, PEAR Therapeutics, SPAC, Substance Use Disorder 0 Comment

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing

Digital health firm Pear goes public, raising $175 million

https://pharmaphorum.com/news/digital-health-firm-pear-goes-pubic-raising-175-million/

Digital/ News/ News

Pear claims breakthrough tag for alcohol use disorder DTx

Phil Taylor alcohol use disorder, Breakthrough Device Designation, digital, digital health, digital therapeutics, PEAR Therapeutics 0 Comment

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic

Pear claims breakthrough tag for alcohol use disorder DTx

https://pharmaphorum.com/news/pear-claims-breakthrough-tag-for-alcohol-use-disorder-dtx/

Digital/ News/ News

Digital therapeutic cuts opioid use disorder care costs, says study

Phil Taylor digital, digital health, opioid use disorder, opioids, PEAR Therapeutics 0 Comment

A real-world study of digital therapeutic (DTx) for opioid use disorder has found that patient show used it

Digital therapeutic cuts opioid use disorder care costs, says study

https://pharmaphorum.com/news/digital-therapeutic-cuts-opioid-use-disorder-care-costs-says-study/

Digital/ News/ News

NIH starts trial of Pear, Chess apps for opioid use disorder

Phil Taylor Chess Health, digital, digital health, digital therapeutics, opioid crisis, opioid use disorder, PEAR Therapeutics 0 Comment

Patient recruitment has begun in a National Institutes of Health (NIH) trial of two digital therapeutics (DTx) for

NIH starts trial of Pear, Chess apps for opioid use disorder

https://pharmaphorum.com/news/nih-starts-trial-of-pear-chess-apps-for-opioid-use-disorder/

Digital/ News/ News

DTx company Pear shapes public listing with $1.6bn SPAC merger

Phil Taylor digital, digital health, digital therapeutics, financing, PEAR Therapeutics, SPAC 0 Comment

Digital health company Pear Therapeutics has foregone the traditional initial public offering (IPO) route to a stock exchange

DTx company Pear shapes public listing with $1.6bn SPAC merger

https://pharmaphorum.com/news/dtx-company-pear-shapes-public-listing-with-1-6bn-spac-merger/

doctor is sending result of medical test to patient

Digital/ News/ News

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

Richard Staines digital therapeutics, opioids, PEAR Therapeutics 0 Comment

A third US state has agreed to fund Pear Therapeutics’ digital therapeutics (DTx) to treat people with substance

Ohio is third state to fund Pear’s digital therapeutics to tackle addiction

https://pharmaphorum.com/news/ohio-is-third-state-to-fund-pears-digital-therapeutics-to-tackle-addiction/

Digital/ News/ News

Digital therapies for opioid use disorder need more data, says ICER

Phil Taylor Chess Health Solutions, digital, digital therapeutics, DynamiCare Health, opioid crisis, opioid use disorder, PEAR Therapeutics 0 Comment

There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve

Digital therapies for opioid use disorder need more data, says ICER

https://pharmaphorum.com/news/digital-therapies-for-opioid-use-disorder-need-more-data-says-icer/

Digital/ News/ News/ Top stories

Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme

Phil Taylor digital, digital theraputics, PEAR Therapeutics, Psychiatry, schizophrenia 0 Comment

Pear Therapeutics has started a limited launch of its digital therapeutic for people living with schizophrenia under the

Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme

https://pharmaphorum.com/news/pear-rolls-out-digital-therapy-for-schizophrenia-under-fdas-covid-19-scheme/

Trending

PEAR Therapeutics

Login